Refine by
Prostate Suppliers Serving Tonga
139 companies found
based inMiami, FLORIDA (USA)
Veru is a biotechnology company focused on developing novel medicines for COVID-19, additional ARDS-related diseases, and for breast and prostate cancers. Veru is a Wisconsin corporation and is the successor to The Wisconsin Pharmacal Company, Inc. ...
based inLatham, NEW YORK (USA)
AngioDynamics, with its disruptive and innovative medical devices, addresses unmet patient needs by elevating the standard of care for chronic and acute disease states in vascular, peripheral vascular, and oncology medicine. These devices provide ...
The IsoLoc Endorectal Balloon’s unique, customer-driven design is the result of collaborations with Radiation Oncologists, Therapists and Physicists with one goal in mind – to create a new standard for endorectal balloons (ERB) in the ...
based inTehran, IRAN
Pars Isotope Co is a prominent supplier and producer of radioisotopes in Iran, catering widely to the medical and industrial sectors. As the sole provider in the region, the company focuses on radiopharmaceuticals used for both the diagnosis and ...
Lu-177-PSMA is a theranostic radiopharmaceutical designed for the treatment of metastatic prostate cancer. Employing the Peptide Receptor Radionuclide Therapy (PRRT) technique, it selectively targets and binds to ...
based inHouston, TEXAS (USA)
Elabscience specializes in immunodiagnostic technology for life science community. We have complete platform for R&D and manufacture. At the same time, we have in house QC for every product, endeavoring to keep your experiment results more ...
In order to facilitate the operation and ensure the accuracy of WB results, the Western Blot Detection kit (Cat# E-IR-R304) is now available, containing the reagents which are needed from sample preparation to result detection. Please order the ...
based inMunchen, GERMANY
NeoControl provides a non-surgical, non-invasive therapy for treatment of: Erectile dysfunction, Premature ejaculation, Hemorrhoids, Urinary and feces Incontinence in both men and women, Incontinence after radical prostatectomy, Chronic prostatitis ...
Extracorporeal Magnetic Innervation (ExMI™) is based on the principle described by Faraday’s Law of Magnetic Induction. In the mid-1800s, Faraday demonstrated that muscular contractions could be induced by the application of a ...
based inBurlington, MASSACHUSETTS (USA)
BK Medical is committed to designing active imaging systems that help surgeons visualize anatomy and lesions, guide interventions, and navigate inside the human body. Our mission at BK is to change the standard of care in surgical interventions with ...
Fusing powerful real-time ultrasound images with pre-exam MRI data gives you better guidance to help accurately target lesions detected on the MRI images, potentially reducing the risk of missing high-grade tumors or under-staging tumors for active ...
based inPetah Tikva, ISRAEL
Isotopia Molecular Imaging was established in 2007 by renowned Israeli scientists and experts in the field of radio pharmaceuticals, and in collaboration with the International Metronotario investment organization. Advancing cancer diagnosis and ...
Lutetium-177 (Lu-177) is being widely used as a promising radionuclide for targeted therapy and is emerging as a game-changing theranostic isotope for the treatment of neuroendocrine tumors, metastatic castration-resistant prostate ...
based inPleasanton, CALIFORNIA (USA)
29 years designing high affinity antibodies and immunoassays. Proudly serving the brightest minds in scientific research. Your experts in offering state-of-the-art ELISA kits, antibodies, custom reagents and analytical services in immunology, ...
based inRegensburg, GERMANY
numares is an innovative diagnostics company. We focus on the discovery, development and commercialization of diagnostic tests, using metabolite constellations to solve unmet medical needs that could not be addressed by single biomarker-based ...
Common cancers with established benefit of early diagnosis but for which there are no sensitive or specific tests are prostate, bladder and liver cancer1. Expensive imaging procedures are routinely required in clinical practice for ...
based inKarlsruhe, GERMANY
Volkmann MedizinTechnik GmbH is a manufacturer of consumables for surgery and related fields of medicine such as urology, orthopedics and traumatology, maxillofacial surgery, neurosurgery, plastic surgery. The head office is located in Karlsruhe, ...
Automatic biopsy needle. Used to take a biopsy from prostate only. Amecath automatic biopsy gun needle is a true-cut type biopsy needle can be used with common reusable biopsy ...
based inBerlin, GERMANY
BEBIG Medical GmbH is a global leader in radiation therapy products focused on cancer treatment, boasting over a half-century of experience in delivering reliable clinical outcomes through advanced technology. The company engages in extensive ...
SagiPlan® is a comprehensive treatment planning software designed to support all HDR brachytherapy applications, including specialized real-time prostate treatments. Featuring a modern user interface, SagiPlan® enhances user ...
based inLeonards, AUSTRALIA
AllVascular is an Australian medical device company based in Sydney. The Company’s lead product is a novel vascular access system called the AVAS. The AVAS is unique as it can facilitate treatments that require frequent vascular access such as the ...
The Sniper can be used with the AVAS for Liver Isolated Oxaliplatin (LIOX) for patients with colorectal liver cancer or on its own to treat primary liver cancer with TACE or SIRT, benign prostate hyperplasia, and uterine ...
based inMiami, FLORIDA (USA)
At OPKO Health, we seek to serve unmet patient needs through our first in class products, comprehensive diagnostics laboratories, robust research and development pipeline, and unique pharmaceutical business solutions. OPKO has grown into a global ...
Selective Androgen Receptor Modulators (SARMs) have recently garnered attention as possible therapeutic agents due to their increased specificity for anabolic androgen receptors, and yet potentially serving as an antagonist to androgen receptors in ...
based inCambridge, MASSACHUSETTS (USA)
Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. entity, together with the oncology research and development teams in Japan, Cancer ...
TP-3654 is an oral investigational inhibitor of PIM kinases, which has potential antitumor and anti-fibrotic effects through multiple pathways, including induction of ...
based inSan Jose, CALIFORNIA (USA)
OptraSCAN’s intelligent digital pathology solutions equip pathologists with high-performing hardware and software to be more efficient, accurate, and consistent. OptraSCAN® is eliminating the barriers to adopting digital pathology no matter the size ...
OS-Ultra is a high-speed whole slide digital pathology scanner that scans tissues/cells of size 15×15 mm area at 40x equivalent in less than 60 seconds. OS-Ultra features a unique no-touch slide loading mechanism to diminish workflow errors ...
based inCarlton, AUSTRALIA
Radiopharm Theranostics has the ambition to become a recognised leader in the development of radiopharmaceutical products for both diagnostic and therapeutic uses in areas of high unmet medical needs. There is unique potential of ...
PSA-mAb is the invention of Professor David Ulmert formerly of Memorial Sloan Kettering and now ...
based inCham, SWITZERLAND
The global healthcare system is fundamentally changing - advances in technology such as robotics and artificial intelligence as well as rising consumer expectations are driving a global shift in the healthcare landscape. Similarly to the ...
Earlier, precise diagnostic of prostate cancer demands a paradigm change respectively a new treatment pathway. SONABLATE HIFU is the image-guided, non-invasive surgical ablation system that delivers precise, focused and controlled ...
based inMilan, ITALY
Bracco is an international Group active in the healthcare sector and a leader in diagnostic imaging. It has around 3,587 employees and annual total consolidated revenues of around 1,4 billion euros, 89% of which from international sales. In the ...
based inPlanegg, GERMANY
MorphoSys is a commercial-stage biopharmaceutical company dedicated to the discovery, development, and delivery of innovative cancer medicines. At MorphoSys, our ambition is to redefine how cancer is treated. As a commercial-stage biopharmaceutical ...
Tulmimetostat is a second-generation EZH2 inhibitor that has been designed to achieve comprehensive target coverage through extended on-target residence time. EZH2 acts as an epigenetic writer and normally places one or more methyl groups on a ...
based inLondon, UNITED KINGDOM
Getting ahead of cancer is crucial no matter where people are in their cancer journey. From earlier cancer detection to treatment guidance and monitoring, we are helping people get the answers they need to make more informed decisions across the ...
Every cancer is unique and affects each diagnosed person differently based on the individual biology of his or her disease. To address this diversity and make cancer care smarter at every stage, our Oncotype DX genomic tests and services portfolio ...